The primary aim of Dr. Grant's research efforts is to improve functioning and quality of life in individuals diagnosed with schizophrenia. This research program has two tracks. The first is an investigation of the psychopathology of schizophrenia, including the primary symptoms of hallucinations, delusions, speech disturbance, negative symptoms, as well as biopsychosocial modeling of functional outcomes, featuring neurocognitive impairments, behavioral skills, and dysfunctional attitudes. The goal of the psychopathology research is a better understanding of the disorder that yields improved clinical formulation and the identification of new treatment targets. Accordingly, the second track of Dr. Grant's research program is the development, evaluation, and dissemination of novel treatments for individuals with schizophrenia. Over the past several years his research has focused upon patients in the lower end of the continuum of functional outcome in both outpatient and inpatient settings.